Hepcidin is a key mediator of anemia of inflammation in Crohn's disease

Robert J. Basseri, Elizabeta Nemeth, Maria Vassilaki, Benjamin Basseri, Pedram Enayati, Omid Shaye, Leonidas A. Bourikas, Tom Ganz, Konstantinos Papadakis

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Anemia often complicates the course of Inflammatory Bowel Disease (IBD). Hepcidin, a liver-produced peptide hormone, is a key mediator of anemia of chronic disease (ACD). We hypothesized that hepcidin is significantly elevated in anemic CD patients and that hepcidin may cause iron restriction and, therefore, mediate ACD. Methods: We enrolled 17 patients with CD and ACD recruited from the Cedars-Sinai IBD Center. Routine blood tests included hemoglobin (Hgb), hematocrit, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Anemia was defined as hemoglobin < 12. g/dL and < 13.5. g/dL, in men and women, respectively. ACD was diagnosed on the basis of a combination of the following: a) normal or elevated ferritin b) lowered serum iron and total iron binding capacity and c) normal percent iron saturation. Serum and urine hepcidin, as well as IL-6 levels were also measured. Patients with documented iron-deficiency anemia were excluded. Results: There was an excellent correlation between urine (expressed as ng/mg of creatinine) and serum hepcidin levels expressed as ng/ml (r = 0.853, p < 0.001). We also found a strong positive correlation between serum hepcidin and ferritin levels (r= 0.723, p= 0.0015). There was a positive correlation between serum hepcidin and IL-6 levels (r= 0.546, p= 0.023). We found a strong negative correlation between serum hepcidin concentrations and Hgb levels (r= 0.528, p= 0.029). Conclusion: We demonstrate that ACD in CD is characterized by high serum IL-6 and hepcidin levels, which negatively correlate with Hgb levels. Our data support the hypothesis that IL-6-driven hepcidin production mediates ACD in patients with CD.

Original languageEnglish (US)
JournalJournal of Crohn's and Colitis
Volume7
Issue number8
DOIs
StatePublished - Sep 1 2013
Externally publishedYes

Fingerprint

Hepcidins
Inflammation Mediators
Crohn Disease
Anemia
Chronic Disease
Serum
Interleukin-6
Hemoglobins
Iron
Ferritins
Inflammatory Bowel Diseases
Urine
Iron-Deficiency Anemias
Peptide Hormones
Blood Sedimentation
Hematologic Tests
Hematocrit
C-Reactive Protein
Creatinine

Keywords

  • Anemia
  • Anemia of chronic disease
  • Crohn's disease
  • Hepcidin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. / Basseri, Robert J.; Nemeth, Elizabeta; Vassilaki, Maria; Basseri, Benjamin; Enayati, Pedram; Shaye, Omid; Bourikas, Leonidas A.; Ganz, Tom; Papadakis, Konstantinos.

In: Journal of Crohn's and Colitis, Vol. 7, No. 8, 01.09.2013.

Research output: Contribution to journalArticle

Basseri, Robert J. ; Nemeth, Elizabeta ; Vassilaki, Maria ; Basseri, Benjamin ; Enayati, Pedram ; Shaye, Omid ; Bourikas, Leonidas A. ; Ganz, Tom ; Papadakis, Konstantinos. / Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. In: Journal of Crohn's and Colitis. 2013 ; Vol. 7, No. 8.
@article{5b82a1fcfd07416c8addf7728418a086,
title = "Hepcidin is a key mediator of anemia of inflammation in Crohn's disease",
abstract = "Anemia often complicates the course of Inflammatory Bowel Disease (IBD). Hepcidin, a liver-produced peptide hormone, is a key mediator of anemia of chronic disease (ACD). We hypothesized that hepcidin is significantly elevated in anemic CD patients and that hepcidin may cause iron restriction and, therefore, mediate ACD. Methods: We enrolled 17 patients with CD and ACD recruited from the Cedars-Sinai IBD Center. Routine blood tests included hemoglobin (Hgb), hematocrit, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Anemia was defined as hemoglobin < 12. g/dL and < 13.5. g/dL, in men and women, respectively. ACD was diagnosed on the basis of a combination of the following: a) normal or elevated ferritin b) lowered serum iron and total iron binding capacity and c) normal percent iron saturation. Serum and urine hepcidin, as well as IL-6 levels were also measured. Patients with documented iron-deficiency anemia were excluded. Results: There was an excellent correlation between urine (expressed as ng/mg of creatinine) and serum hepcidin levels expressed as ng/ml (r = 0.853, p < 0.001). We also found a strong positive correlation between serum hepcidin and ferritin levels (r= 0.723, p= 0.0015). There was a positive correlation between serum hepcidin and IL-6 levels (r= 0.546, p= 0.023). We found a strong negative correlation between serum hepcidin concentrations and Hgb levels (r= 0.528, p= 0.029). Conclusion: We demonstrate that ACD in CD is characterized by high serum IL-6 and hepcidin levels, which negatively correlate with Hgb levels. Our data support the hypothesis that IL-6-driven hepcidin production mediates ACD in patients with CD.",
keywords = "Anemia, Anemia of chronic disease, Crohn's disease, Hepcidin",
author = "Basseri, {Robert J.} and Elizabeta Nemeth and Maria Vassilaki and Benjamin Basseri and Pedram Enayati and Omid Shaye and Bourikas, {Leonidas A.} and Tom Ganz and Konstantinos Papadakis",
year = "2013",
month = "9",
day = "1",
doi = "10.1016/j.crohns.2012.10.013",
language = "English (US)",
volume = "7",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Hepcidin is a key mediator of anemia of inflammation in Crohn's disease

AU - Basseri, Robert J.

AU - Nemeth, Elizabeta

AU - Vassilaki, Maria

AU - Basseri, Benjamin

AU - Enayati, Pedram

AU - Shaye, Omid

AU - Bourikas, Leonidas A.

AU - Ganz, Tom

AU - Papadakis, Konstantinos

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Anemia often complicates the course of Inflammatory Bowel Disease (IBD). Hepcidin, a liver-produced peptide hormone, is a key mediator of anemia of chronic disease (ACD). We hypothesized that hepcidin is significantly elevated in anemic CD patients and that hepcidin may cause iron restriction and, therefore, mediate ACD. Methods: We enrolled 17 patients with CD and ACD recruited from the Cedars-Sinai IBD Center. Routine blood tests included hemoglobin (Hgb), hematocrit, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Anemia was defined as hemoglobin < 12. g/dL and < 13.5. g/dL, in men and women, respectively. ACD was diagnosed on the basis of a combination of the following: a) normal or elevated ferritin b) lowered serum iron and total iron binding capacity and c) normal percent iron saturation. Serum and urine hepcidin, as well as IL-6 levels were also measured. Patients with documented iron-deficiency anemia were excluded. Results: There was an excellent correlation between urine (expressed as ng/mg of creatinine) and serum hepcidin levels expressed as ng/ml (r = 0.853, p < 0.001). We also found a strong positive correlation between serum hepcidin and ferritin levels (r= 0.723, p= 0.0015). There was a positive correlation between serum hepcidin and IL-6 levels (r= 0.546, p= 0.023). We found a strong negative correlation between serum hepcidin concentrations and Hgb levels (r= 0.528, p= 0.029). Conclusion: We demonstrate that ACD in CD is characterized by high serum IL-6 and hepcidin levels, which negatively correlate with Hgb levels. Our data support the hypothesis that IL-6-driven hepcidin production mediates ACD in patients with CD.

AB - Anemia often complicates the course of Inflammatory Bowel Disease (IBD). Hepcidin, a liver-produced peptide hormone, is a key mediator of anemia of chronic disease (ACD). We hypothesized that hepcidin is significantly elevated in anemic CD patients and that hepcidin may cause iron restriction and, therefore, mediate ACD. Methods: We enrolled 17 patients with CD and ACD recruited from the Cedars-Sinai IBD Center. Routine blood tests included hemoglobin (Hgb), hematocrit, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Anemia was defined as hemoglobin < 12. g/dL and < 13.5. g/dL, in men and women, respectively. ACD was diagnosed on the basis of a combination of the following: a) normal or elevated ferritin b) lowered serum iron and total iron binding capacity and c) normal percent iron saturation. Serum and urine hepcidin, as well as IL-6 levels were also measured. Patients with documented iron-deficiency anemia were excluded. Results: There was an excellent correlation between urine (expressed as ng/mg of creatinine) and serum hepcidin levels expressed as ng/ml (r = 0.853, p < 0.001). We also found a strong positive correlation between serum hepcidin and ferritin levels (r= 0.723, p= 0.0015). There was a positive correlation between serum hepcidin and IL-6 levels (r= 0.546, p= 0.023). We found a strong negative correlation between serum hepcidin concentrations and Hgb levels (r= 0.528, p= 0.029). Conclusion: We demonstrate that ACD in CD is characterized by high serum IL-6 and hepcidin levels, which negatively correlate with Hgb levels. Our data support the hypothesis that IL-6-driven hepcidin production mediates ACD in patients with CD.

KW - Anemia

KW - Anemia of chronic disease

KW - Crohn's disease

KW - Hepcidin

UR - http://www.scopus.com/inward/record.url?scp=84880039507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880039507&partnerID=8YFLogxK

U2 - 10.1016/j.crohns.2012.10.013

DO - 10.1016/j.crohns.2012.10.013

M3 - Article

VL - 7

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 8

ER -